https://www.selleckchem.com/pr....oducts/napabucasin.h
The relationships between the mean and maximum esophageal doses and incidence of dysphagia, esophagitis or mucositis were estimated and dose response curves determined. Results Eleven patients reported esophageal symptoms (average duration eleven days, range 1-18 days). Incidence of esophageal toxicity in patients treated at Th8 or above was 79 percent, while no patients treated below Th8 reported any symptoms (p less then 0.001). Furthermore, 2 out of 3 patients irradiated at the cervical region reported substantial changes in ta
Like
Comment
Share
